Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 2,360,139 12.400% |
655,809 (+38.48%) |
Filing History |
| 2021-02-16 1:29 pm Sale |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
ArrowMark Colorado Holdings LLC | 751,495 3.900% |
-115,555 (-13.33%) |
Filing History |
| 2021-02-12 1:16 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
2,447,000 12.830% |
1,010,000 (+70.29%) |
Filing History |
| 2021-02-12 07:01 am Sale |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Satter Muneer A | 0 0.000% |
-832,000 (Position Closed) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
BLACKROCK INC BLK |
1,242,780 6.500% |
556,324 (+81.04%) |
Filing History |
| 2020-10-23 5:05 pm Sale |
2019-11-06 | 13D | Albireo Pharma, Inc. ALBO |
TVM Life Science Ventures VI LP | 0 0.000% |
-621,761 (Position Closed) |
Filing History |